UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

Clinical pharmacology and therapeutics, 2014-04, Vol.95 (4), p.376-382

2014

Volltextzugriff (PDF)

Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics

Clinical pharmacology and therapeutics, 2016-10, Vol.100 (4), p.362-370

2016

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.321-326

2012

Volltextzugriff (PDF)

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44

2017

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron

Clinical pharmacology and therapeutics, 2017-08, Vol.102 (2), p.213-218

2017

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Clinical pharmacology and therapeutics, 2015-08, Vol.98 (2), p.127-134

2015

Volltextzugriff (PDF)

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44

2017

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Clinical pharmacology and therapeutics, 2013-05, Vol.93 (5), p.402-408

2013

Volltextzugriff (PDF)

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study

Clinical pharmacology and therapeutics, 2009-01, Vol.85 (1), p.31-35

2009

Volltextzugriff (PDF)

Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver

Clinical pharmacology and therapeutics, 2015-08, Vol.98 (2), p.205-215

2015

Volltextzugriff (PDF)

The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

Clinical pharmacology and therapeutics, 2008-02, Vol.83 (2), p.234-242

2008

Volltextzugriff (PDF)

Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD

Clinical pharmacology and therapeutics, 2016-06, Vol.99 (6), p.642-650

2016

Volltextzugriff (PDF)

Ontogeny of Dextromethorphan O‐ and N‐demethylation in the First Year of Life

Clinical pharmacology and therapeutics, 2007-04, Vol.81 (4), p.510-516

2007

Volltextzugriff (PDF)

Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children

Drug metabolism and disposition, 2016-07, Vol.44 (7), p.1070-1079

2016

Volltextzugriff (PDF)

Cytochrome P4502D6 ( ) Gene Locus Heterogeneity: Characterization of Gene Duplication Events

Clinical pharmacology and therapeutics, 2007-02, Vol.81 (2), p.242-251

2007

Volltextzugriff (PDF)

Polymorphisms in CYP2D6 may predict methamphetamine related heart failure

Clinical toxicology (Philadelphia, Pa.), 2013-08, Vol.51 (7), p.540-544

2013

Volltextzugriff (PDF)

Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity

Pediatric obesity, 2019-01, Vol.14 (1), p.n/a

2019

Volltextzugriff (PDF)

Assessment of Activity Levels for CYP2D61, CYP2D62, and CYP2D641 Genes by Population Pharmacokinetics of Dextromethorphan

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.643-651

2010

Volltextzugriff (PDF)

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans

Clinical pharmacology and therapeutics, 2002-07, Vol.72 (1), p.76-89

2002

Volltextzugriff (PDF)

Safety of codeine during breastfeeding Fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine

Canadian family physician, 2007-01, Vol.53 (1), p.33-35

2007

Volltextzugriff (PDF)

Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort

The pharmacogenomics journal, 2016-11, Vol.16 (6), p.566-572

2016

Volltextzugriff (PDF)

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database

Clinical pharmacology and therapeutics, 2018-03, Vol.103 (3), p.399-401

2018

Volltextzugriff (PDF)

Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort

The pharmacogenomics journal, 2017-07, Vol.17 (4), p.393-393

2017

Volltextzugriff (PDF)

Interethnic differences of drug-metabolizing enzymes

International journal of clinical pharmacology and therapeutics, 2000-02, Vol.38 (2), p.61-68

Gaedigk, A

2000

Volltextzugriff (PDF)

Identification and characterization of novel sequence variations in the cytochrome P4502D6 ( ) gene in African Americans

The pharmacogenomics journal, 2005-01, Vol.5 (3), p.173-182

2005

Volltextzugriff (PDF)

1 – 25 von 453

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(430)
Mit Volltextzugriff
(358)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(297)
Life Sciences & Biomedicine
(291)
Humans
(243)
Pharmacology & Pharmacy
(174)
Genotype
(111)
Cytochrome P-450 Cyp2d6 - Genetics
(98)
Female
(89)
Male
(86)
Biological And Medical Sciences
(83)
Alleles
(69)
Pharmacogenetics
(68)
Medical Sciences
(65)
Phenotype
(60)
Child
(59)
Adult
(57)
Adolescent
(50)
Cyp2d6
(49)
Pharmacology. Drug Treatments
(47)
Cytochrome P-450 Cyp2d6 - Metabolism
(46)
Genetics & Heredity
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study

Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver

The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD

Ontogeny of Dextromethorphan O‐ and N‐demethylation in the First Year of Life

Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children

Cytochrome P4502D6 ( ) Gene Locus Heterogeneity: Characterization of Gene Duplication Events

Polymorphisms in CYP2D6 may predict methamphetamine related heart failure

Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity

Assessment of Activity Levels for CYP2D61, CYP2D62, and CYP2D641 Genes by Population Pharmacokinetics of Dextromethorphan

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans

Safety of codeine during breastfeeding Fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine

Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database

Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort

Interethnic differences of drug-metabolizing enzymes

Identification and characterization of novel sequence variations in the cytochrome P4502D6 ( ) gene in African Americans

Suchergebnisse filtern